BRAF and melanoma: Another study tested the impact of blocking the ABCB5 transporter on recurrent melanoma, but found that knockdown of ABCB5 did not re-sensitize BRAF inhibitor-resistant melanoma cell lines, in spite of the fact that ABCB5 is highly expressed in malignant melanoma-initiating cells [207].